Health & Fitness

Journal of Clinical Oncology (JCO) Podcast

by American Society of Clinical Oncology (ASCO)

Today: #132 in Health & Fitness, Brazil on our combined chart.

Share this ranking Claiming needs an RSS feed. Contact us.

Listen on Apple Podcasts

Chart positions today · Brazil

Health & Fitness

#132

#87 Pulse 7

If you like Journal of Clinical Oncology (JCO)…, try…

ASCO Daily News

From American Society of Clinical Oncology (ASCO)

The NRG Oncology Podcast

Ranking history · Brazil

Health & Fitness

Latest daily rankings: Oct 22. New rankings will appear after the next update.

History builds daily. We started tracking this show on the Health & Fitness, Brazil chart recently, so the trend line appears after a second day of data.

View as table

Date	Combined Rank	Apple Podcasts
Oct 22	#132	#87

Latest episodes

pCR Rates and Predictors With THP in HER2-Positive Breast Cancer: EA1181/CompassHER2 pCR

October 8, 2026 · 21 min

What pCR rates can be achieved with neoadjuvant THP, and which patients are most likely to respond? Host Dr. Davide Soldato interviews Dr. Nadine Tung on her article, "Pathologic Complete Response (pCR) Rate and Predictors of Response to…
JCO Article Insights: Long-Term Follow-Up of Weekly Cisplatin + RT in Postoperative HNC

September 28, 2026 · 18 min

Host Dr. Jake New interviews Dr. Makoto Tahara about the JCO article "Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck…
Dexrazoxane and Long-Term Cardiac Function After Doxorubicin: Insights From COG ALTE11C2

September 10, 2026 · 23 min

How does dexrazoxane affect left ventricular function over time after doxorubicin treatment for childhood cancer? Host Dr. Davide Soldato sits down with Dr. Erin Mobley and Dr. Eric Chow to discuss their article, "Longitudinal Change in…
Bladder Adjuvant RadioTherapy (BART) RCT for High Risk MIBC

August 13, 2026 · 18 min

Guest Dr. Vedang Murthy and host Davide Soldato discuss JCO article, "Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder…
JCO Article Insights: Duvelisib in Patients with Relapsed or Refractory PTCL

July 27, 2026 · 11 min

In this episode of JCO Article Insights, host Ash Gurumurthi summarizes the article "Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral…

Show 7 more episodesShow fewer episodes

Effectiveness of a Virtual Tobacco Treatment for Cancer Patients

July 16, 2026 · 24 min

Guests Dr. Elise Park, Dr. Jamie Ostrov and host Dr. Davide Soldato discuss JCO article "Virtual Sustained Tobacco Treatment for Cancer Patients: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) within the NCI Community Oncology…
Phase 2 Study of Multi-Cancer Detection from Breath Samples

June 11, 2026 · 20 min

Guests Akash Kulgod and Dr. Sanjeev Kulgod and host Dr. Davide Soldato discuss JCO article, "Canine Olfaction Combined with Bayesian Modeling for Multi Cancer Detection from Breath Samples, a Phase 2 Study in India" and the innovative…
JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma

June 1, 2026 · 10 min

JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026 Simultaneous Publication paper "Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma…
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

June 1, 2026 · 12 min

JCO Podcast host Dr. Davide Soldato and JCO Associate Editor Dr. Dr. Eileen M. O'Reilly discuss the ASCO 2026 Simultaneous Publication paper "Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor…
JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS

May 31, 2026 · 11 min

JCO Editorial Fellow Dr. Yuvanesh Vedaraju and JCO Associate Editor Dr. Kathy Miller discuss the ASCO 2026 Simultaneous Publication paper "Low-Dose Tamoxifen in Non-Invasive Breast Neoplasia: Long-Term Results from an Individual…
JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC

May 31, 2026 · 9 min

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Umang Swami discuss the ASCO 2026 Simultaneous Publication paper "Neoadjuvant Sacituzumab Govitecan in Patients with Muscle-Invasive Bladder Cancer: Primary Results of SURE-01…
JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC

May 29, 2026 · 13 min

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Andrea Necchi discuss the ASCO 2026 Simultaneous Publication paper "Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder…

Full episode archive on Apple Podcasts →

About the show

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO's flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence into clinical practice. The year's fellows interview authors and summarize the top Journal of Clinical Oncology articles in the series, JCO Article Insights.